DEFA14A

Proxy Materials

Phathom Pharmaceuticals, Inc. Filed 2020-04-08 Acc 0001564590-20-015850

Documents 1

DEFA14A Proxy Materials , phat-defa14a_20200521.htm

Around this filing

2021-04-06 DEFA14A Proxy Materials
2020-04-08 DEFA14A Proxy Materials
2020-04-08 DEF 14A Proxy Statement
2020-04-03 4 10% owner bought 117,600 shares at $24.86 ($2,923,642)

Link to a passage

External

SEC EDGAR (opens in new tab)